Read in Frontiers in Immunology our Published Research
Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models.
A clinical-stage oncology company advancing Targeted Hyperthermia Therapy for solid tumors, powered by uniquely biocompatible, CTAB-free gold nanorods.
Science
News & Media
© 2026 Sona Nanotech Inc. All rights reserved.
CSE: SONA · OTCQB: SNANF